| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $181K | — | -1.3% |
| SG&A Expense | $2.7M | — | -10.8% |
| Operating Income | -$2.9M | — | +10.3% |
| Pre-tax Income | -$2.3M | — | +11.5% |
| Income Tax | $46K | — | -13.2% |
| Net Income | -$1.2M | — | +3.2% |
| EPS (Basic) | -$0.05 | — | +37.5% |
| EPS (Diluted) | -$0.05 | — | +37.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.3M | -5.1% | -16.8% |
| Accounts Receivable | $4K | -97.2% | -99.4% |
| Current Assets | $55.3M | -4.5% | -17.6% |
| Total Assets | $57.9M | -3.9% | -18.8% |
| Current Liabilities | $1.5M | -26.7% | -55.5% |
| Total Liabilities | $1.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | +29.3% |
| Capital Expenditures | $458K | — | -3.2% |
| Investing Cash Flow | -$317K | — | -2553.6% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$3.1M | — | +26.3% |
| -55.7% |
| Stockholders' Equity | $56.3M | -3.1% | -16.8% |